Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lea Lowenfeld

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Endoscopy|July 20, 2021
Novel percutaneous access to the large intestine using a double-balloon endoluminal platform for excision of a large polypShinya Urakawa, Daniel Joseph Holzwanger, Teijiro Hirashita, et al.
The Yale Journal of Biology and Medicine|December 16, 2014
Optimizing dendritic cell-based approaches for cancer immunotherapyJashodeep Datta, Julia H Terhune, Lea Lowenfeld, et al.
Annals of Surgical Oncology|June 24, 2015
Multimodality Treatment of T4 Gastric Cancer in the United States: Utilization Trends and Impact on SurvivalLea Lowenfeld, Jashodeep Datta, Russell S Lewis, et al.
Annals of Surgical Oncology|April 20, 2016
Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United StatesJashodeep Datta, Matthew T McMillan, Luis Ruffolo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2016
Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2<sup>pos</sup> DCIS Independent of Route: Results of Randomized Selection Design TrialLea Lowenfeld, Rosemarie Mick, Jashodeep Datta, et al.
Breast Cancer Research : BCR|May 23, 2015
Anti-HER2 CD4(+) T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancerJashodeep Datta, Erik Berk, Shuwen Xu, et al.
Oncoimmunology|September 22, 2017
Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ER<sup>pos</sup>/HER2<sup>pos</sup> early breast cancerLea Lowenfeld, Salman Zaheer, Crystal Oechsle, et al.
Oncogene|September 21, 2023
Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancerPashtoon Murtaza Kasi, Manuel Hidalgo, Mehraneh D Jafari, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Endoscopy|July 20, 2021
Novel percutaneous access to the large intestine using a double-balloon endoluminal platform for excision of a large polypShinya Urakawa, Daniel Joseph Holzwanger, Teijiro Hirashita, et al.
The Yale Journal of Biology and Medicine|December 16, 2014
Optimizing dendritic cell-based approaches for cancer immunotherapyJashodeep Datta, Julia H Terhune, Lea Lowenfeld, et al.
Annals of Surgical Oncology|June 24, 2015
Multimodality Treatment of T4 Gastric Cancer in the United States: Utilization Trends and Impact on SurvivalLea Lowenfeld, Jashodeep Datta, Russell S Lewis, et al.
Annals of Surgical Oncology|April 20, 2016
Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United StatesJashodeep Datta, Matthew T McMillan, Luis Ruffolo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2016
Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2<sup>pos</sup> DCIS Independent of Route: Results of Randomized Selection Design TrialLea Lowenfeld, Rosemarie Mick, Jashodeep Datta, et al.
Breast Cancer Research : BCR|May 23, 2015
Anti-HER2 CD4(+) T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancerJashodeep Datta, Erik Berk, Shuwen Xu, et al.
Oncoimmunology|September 22, 2017
Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ER<sup>pos</sup>/HER2<sup>pos</sup> early breast cancerLea Lowenfeld, Salman Zaheer, Crystal Oechsle, et al.
Oncogene|September 21, 2023
Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancerPashtoon Murtaza Kasi, Manuel Hidalgo, Mehraneh D Jafari, et al.
Pageof 2